New approach methods on the bench side to accelerate clinical trials during pregnancy

References

• Lawn JE, Kinney MV, Belizan JM, et al. Born too soon: accelerating actions for prevention and care of 15 million newborns born too soon. Reprod Health. 2013;10(Suppl 1):S6. doi: 10.1186/1742-4755-10-S1-S6
   PubMedGoogle Scholar
• Beck S, Wojdyla D, Say L, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ. 2010 Jan;88(1):31–38. doi: 10.2471/BLT.08.062554
   PubMed Web of Science ®Google Scholar
• Qiao C, Menon R, Ahn KH, et al. Preterm birth update in Australasia: a report of the international symposium of preterm birth international Collaborative-Australasia branch. Front Pediatr. 2022;10:903546. doi: 10.3389/fped.2022.903546
   PubMed Web of Science ®Google Scholar
• Menon R. Spontaneous preterm birth, a clinical dilemma: etiologic, pathophysiologic and genetic heterogeneities and racial disparity. Acta Obstet Gynecol Scand. 2008;87(6):590–600. doi: 10.1080/00016340802005126
   PubMed Web of Science ®Google Scholar
• Vidal MS Jr., Lintao RCV, Severino MEL, et al. Spontaneous preterm birth: involvement of multiple feto-maternal tissues and organ systems, differing mechanisms, and pathways. Front Endocrinol. 2022;13:1015622. doi: 10.3389/fendo.2022.1015622
   PubMed Web of Science ®Google Scholar
• Berezowska M, Sharma P, Pilla Reddy V, et al. Physiologically based pharmacokinetic modelling of drugs in pregnancy: a mini-review on availability and limitations. Fundam Clin Pharmacol. 2023 Nov 15:e12967. doi: 10.1111/fcp.12967
   PubMed Web of Science ®Google Scholar
• Kammala A, Benson M, Ganguly E, et al. Fetal membranes contribute to drug transport across the feto-maternal interface utilizing the breast cancer resistance protein (BCRP). Life (Basel). 2022 Jan 23;12(2):166. doi: 10.3390/life12020166
   PubMed Web of Science ®Google Scholar
• Lintao RCV, Kammala AK, Vora N, et al. Fetal membranes exhibit similar nutrient transporter expression profiles to the placenta. Placenta. 2023 Apr;135:33–42. doi: 10.1016/j.placenta.2023.03.001
   PubMed Web of Science ®Google Scholar
• Kammala AK, Lintao RCV, Vora N, et al. Expression of CYP450 enzymes in human fetal membranes and its implications in xenobiotic metabolism during pregnancy. Life Sci. 2022 Aug;5:120867. doi: 10.1016/j.lfs.2022.120867
   Google Scholar
• Dorey RB, Theodosiou AA, Read RC, et al. Qualitative interview study exploring the perspectives of pregnant women on participating in controlled human infection research in the UK. BMJ Open. 2023 Dec 27;13(12):e073992. doi: 10.1136/bmjopen-2023-073992
   PubMed Web of Science ®Google Scholar
• Bank TC, Stika CS, Venkataramanan R, et al. Challenges in conducting therapeutic trials in pregnancy: emphasizing recent lessons learned. J Clin Pharmacol. 2023 Jun;63(Suppl 1):S117–S125. doi: 10.1002/jcph.2226
   PubMedGoogle Scholar
• Adams Waldorf KM, Rubens CE, Gravett MG. Use of nonhuman primate models to investigate mechanisms of infection-associated preterm birth. BJOG. 2011 Jan;118(2):136–144. doi: 10.1111/j.1471-0528.2010.02728.x
   PubMed Web of Science ®Google Scholar
• Menon R, Muglia LJ, Levin LH. Review on new approach methods to gain insight into the feto-maternal interface physiology. Front Med. 2023;10:1304002. doi: 10.3389/fmed.2023.1304002
   Web of Science ®Google Scholar
• Pu Y, Gingrich J, Veiga-Lopez A. A 3-dimensional microfluidic platform for modeling human extravillous trophoblast invasion and toxicological screening. Lab Chip. 2021 Feb 9;21(3):546–557. doi: 10.1039/D0LC01013H
   PubMed Web of Science ®Google Scholar
• Yin F, Zhu Y, Zhang M, et al. A 3D human placenta-on-a-chip model to probe nanoparticle exposure at the placental barrier. Toxicol Vitro. 2019 Feb;54:105–113. doi: 10.1016/j.tiv.2018.08.014
   PubMed Web of Science ®Google Scholar
• Mosavati B, Oleinikov A, Du E. 3D microfluidics-assisted modeling of glucose transport in placental malaria. Sci Rep. 2022 Sep 10;12(1):15278. doi: 10.1038/s41598-022-19422-y
   PubMed Web of Science ®Google Scholar
• Zubizarreta ME, Xiao S. Bioengineering models of female reproduction. Biodes Manuf. 2020 Sep;3(3):237–251. doi: 10.1007/s42242-020-00082-8
   PubMed Web of Science ®Google Scholar
• Mosavati B, Oleinikov AV, Du E. Development of an organ-on-a-chip-device for study of placental pathologies. Int J Mol Sci. 2020 Nov 19;21(22):8755. doi: 10.3390/ijms21228755
   PubMed Web of Science ®Google Scholar
• Rabussier G, Bunter I, Bouwhuis J, et al. Healthy and diseased placental barrier on-a-chip models suitable for standardized studies. Acta Biomater. 2023 Jul 1;164:363–376. doi: 10.1016/j.actbio.2023.04.033
   PubMed Web of Science ®Google Scholar
• Cui Y, Zhao H, Wu S, et al. Human female reproductive system organoids: applications in developmental biology, disease modelling, and drug discovery. Stem Cell Rev And Rep. 2020 Dec;16(6):1173–1184. doi: 10.1007/s12015-020-10039-0
   PubMed Web of Science ®Google Scholar
• Zarrintaj P, Saeb MR, Stadler FJ, et al. Human organs-on-chips: a review of the state-of-the-art, Current prospects, and future challenges. Adv Biol (Weinh). 2022 Jan;6(1):e2000526. doi: 10.1002/adbi.202000526
   PubMedGoogle Scholar
• Kammala AK, Richardson LS, Radnaa E, et al. Microfluidic technology and simulation models in studying pharmacokinetics during pregnancy. Front Pharmacol. 2023;14:1241815. doi: 10.3389/fphar.2023.1241815
   PubMed Web of Science ®Google Scholar
• Horii M, Touma O, Bui T, et al. Modeling human trophoblast, the placental epithelium at the maternal fetal interface. Reproduction. 2020 Jul;160(1):R1–R11. doi: 10.1530/REP-19-0428
   PubMed Web of Science ®Google Scholar
• Tutar R, Celebi-Saltik B. Modeling of artificial 3D human placenta. Cells Tissues Organs. 2022;211(4):527–536. doi: 10.1159/000511571
   PubMed Web of Science ®Google Scholar
• Mittal R, Woo FW, Castro CS, et al. Organ-on-chip models: implications in drug discovery and clinical applications. J Cell Physiol. 2019 Jun;234(6):8352–8380. doi: 10.1002/jcp.27729
   PubMed Web of Science ®Google Scholar
• Richardson L, Kim S, Menon R, et al. Organ-on-chip technology: The future of feto-maternal interface research? Front Physiol. 2020;11:715. doi: 10.3389/fphys.2020.00715
   PubMed Web of Science ®Google Scholar
• Menon R, Richardson L. Organ-on-a-chip for perinatal biology experiments. Placenta Reprod Med. 2022 Jul;6:1. doi: 10.54844/prm.2022.0098
   Google Scholar
• Richardson L, Jeong S, Kim S, et al. Amnion membrane organ-on-chip: an innovative approach to study cellular interactions. FASEB J. 2019 Aug;33(8):8945–8960. doi: 10.1096/fj.201900020RR
   PubMed Web of Science ®Google Scholar
• Richardson LS, Kammala AK, Kim S, et al. Development of oxidative stress-associated disease models using feto-maternal interface organ-on-a-chip. FASEB J. 2023 Jul;37(7):e23000. doi: 10.1096/fj.202300531R
   PubMed Web of Science ®Google Scholar
• Tantengco OAG, Richardson LS, Radnaa E, et al. Exosomes from Ureaplasma parvum-infected ectocervical epithelial cells promote feto-maternal interface inflammation but are insufficient to cause preterm delivery. Front Cell Dev Biol. 2022;10:931609. doi: 10.3389/fcell.2022.931609
   PubMed Web of Science ®Google Scholar
• Radnaa E, Richardson LS, Sheller-Miller S, et al. Extracellular vesicle mediated feto-maternal HMGB1 signaling induces preterm birth. Lab Chip. 2021 May 18;21(10):1956–1973. doi: 10.1039/D0LC01323D
   PubMed Web of Science ®Google Scholar
• Richardson L, Gnecco J, Ding T, et al. Fetal membrane organ-on-chip: an innovative approach to study cellular interactions. Reprod Sci. 2019 Feb;21:1933719119828084. doi: 10.1177/1933719119828084
   Google Scholar
• Richardson LS, Kim S, Han A, et al. Modeling ascending infection with a feto-maternal interface organ-on-chip. Lab Chip. 2020 Oct 28;20(23):4486–4501. doi: 10.1039/D0LC00875C
   PubMed Web of Science ®Google Scholar
• Tantengco OAG, Richardson LS, Radnaa E, et al. Modeling ascending ureaplasma parvum infection through the female reproductive tract using vagina-cervix-decidua-organ-on-a-chip and feto-maternal interface-organ-on-a-chip. FASEB J. 2022 Oct;36(10):e22551. doi: 10.1096/fj.202200872R
   PubMed Web of Science ®Google Scholar
• Kim S, Richardson L, Radnaa E, et al. Molecular mechanisms of environmental toxin cadmium at the feto-maternal interface investigated using an organ-on-chip (FMi-OOC) model. J Hazard Mater. [2022 Jan 15];422:126759. doi: 10.1016/j.jhazmat.2021.126759
   PubMed Web of Science ®Google Scholar
• Tantengco OAG, Richardson LS, Medina PMB, et al. Organ-on-chip of the cervical epithelial layer: a platform to study normal and pathological cellular remodeling of the cervix. FASEB J. 2021 Apr;35(4):e21463. doi: 10.1096/fj.202002590RRR
   PubMed Web of Science ®Google Scholar
• Yang L, Semmes EC, Ovies C, et al. Innate immune signaling in trophoblast and decidua organoids defines differential antiviral defenses at the maternal-fetal interface. Elife. 2022 Aug 17; 11;11. doi: 10.7554/eLife.79794
   Web of Science ®Google Scholar
• Yang L, Liang P, Yang H, et al. Trophoblast organoids with physiological polarity model placental structure and function. J Cell Sci. 2024 Mar 1;137(5). doi: 10.1242/jcs.261528
   Web of Science ®Google Scholar
• McKiever M, Frey H, Costantine MM. Challenges in conducting clinical research studies in pregnant women. J Pharmacokinet Pharmacodyn. 2020 Aug;47(4):287–293. doi: 10.1007/s10928-020-09687-z
   PubMed Web of Science ®Google Scholar
• Tabatabaei Rezaei N, Kumar H, Liu H, et al. Recent advances in organ-on-chips integrated with bioprinting technologies for drug screening. Adv Healthc Mater. 2023 Aug;12(20):e2203172. doi: 10.1002/adhm.202203172
   PubMed Web of Science ®Google Scholar
• Gholizadeh H, Cheng S, Kourmatzis A, et al. Application of micro-engineered kidney, liver, and respiratory system models to accelerate preclinical drug testing and development. Bioeng (Basel). 2022 Apr 2;9(4):150. doi: 10.3390/bioengineering9040150
   PubMedGoogle Scholar
• Lacombe J, Soldevila M, Zenhausern F. From organ-on-chip to body-on-chip: the next generation of microfluidics platforms for in vitro drug efficacy and toxicity testing. Prog Mol Biol Transl Sci. 2022;187(1):41–91.
   PubMedGoogle Scholar
• Haderspeck JC, Chuchuy J, Kustermann S, et al. Organ-on-a-chip technologies that can transform ophthalmic drug discovery and disease modeling. Expert Opin Drug Discov. 2019 Jan;14(1):47–57. doi: 10.1080/17460441.2019.1551873
   PubMed Web of Science ®Google Scholar
• Richardson LS, KK A, Costantine MM, et al. Testing of drugs using human feto-maternal interface organ-on-chips provide insights into pharmacokinetics and efficacy. Lab Chip. 2022 Nov 22;22(23):4574–4592. doi: 10.1039/D2LC00691J
   PubMed Web of Science ®Google Scholar
• Arumugasaamy N, Rock KD, Kuo CY, et al. Microphysiological systems of the placental barrier. Adv Drug Deliv Rev. 2020;161-162:161–175. doi: 10.1016/j.addr.2020.08.010
   PubMed Web of Science ®Google Scholar
• Lee JS, Romero R, Han YM, et al. Placenta-on-a-chip: a novel platform to study the biology of the human placenta. J Matern Fetal Neonatal Med. 2016;29(7):1046–1054. doi: 10.3109/14767058.2015.1038518
   PubMed Web of Science ®Google Scholar
• Melody Safarzadeh LR, Han A, Menon R. Development of a multi-organ-on-chip to study maternal-to-fetal transmission of infection and inflammation during pregnancy. Society of Reproductive Investigation. Abstract Book. 20232023. Available from: https://www.myendnoteweb.com/EndNoteWeb.html?func=downloadInstallers&cat=download&
   Google Scholar
• Zhang F, Bartels M, Clark A, et al. Performance evaluation of the GastroPlus. SAR QSAR Environ Res. 2018 Nov;29(11):875–893. doi: 10.1080/1062936X.2018.1518928
   PubMed Web of Science ®Google Scholar
• Varma MV, Lai Y, Feng B, et al. Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions. Pharm Res. 2012 Oct;29(10):2860–2873. doi: 10.1007/s11095-012-0792-7
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020 Feb 7;367(6478). doi: 10.1126/science.aau6977
   PubMed Web of Science ®Google Scholar
• Sheller-Miller S, Lei J, Saade G, et al. Feto-maternal trafficking of exosomes in murine pregnancy models. Front Pharmacol. 2016;7:432. doi: 10.3389/fphar.2016.00432
   PubMed Web of Science ®Google Scholar
• Sheller-Miller S, Radnaa E, Yoo JK, et al. Exosomal delivery of NF-kappaB inhibitor delays LPS-induced preterm birth and modulates fetal immune cell profile in mouse models. Sci Adv. 2021 Jan;7(4). doi: 10.1126/sciadv.abd3865
   PubMed Web of Science ®Google Scholar
• Kammala AK, Mosebarger A, Radnaa E, et al. Extracellular Vesicles-mediated recombinant IL-10 protects against ascending infection-associated preterm birth by reducing fetal inflammatory response. Front Immunol. 2023;14:1196453. doi: 10.3389/fimmu.2023.1196453
   PubMed Web of Science ®Google Scholar